問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2023-12-01 - 2027-12-31
Condition/Disease
Non-Small Cell Lung Cancer
Test Drug
MYTX-011
Participate Sites6Sites
Recruiting6Sites
2023-04-01 - 2025-12-31
Locally Advanced Solid Tumor、 Metastatic Solid Tumor
膜衣錠
Participate Sites3Sites
Recruiting3Sites
2022-07-01 - 2027-02-26
Participate Sites8Sites
Not yet recruiting4Sites
Recruiting4Sites
Participate Sites9Sites
Recruiting9Sites
2021-09-01 - 2026-12-31
Participate Sites5Sites
Recruiting5Sites
2022-05-01 - 2024-08-16
2021-10-01 - 2024-07-31
2022-04-18 - 2023-05-16
Recruiting2Sites
Terminated1Sites
2023-07-01 - 2026-06-30
Participate Sites4Sites
2023-03-01 - 2026-10-30
HER2 Mutant Non-small Cell Lung Cancer
膠囊劑 注射劑 注射劑
全部
